Clinical updates, including trial initiations, enrollment status and data readouts and publications: Castle Biosciences, Dermasensor.

New hires and promotions in the med-tech industry, including: Boston Imaging, Inspiremd.

The top 10 biopharma stock gainers and losers for the week.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Ipsen, Kuria, Likang, Novartis, Pfizer, Sarepta.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Acer, Bristol Myers Squibb, Canbridge, Hanmi, Janssen, Jounce, Leo, Matrivax, Merck, Pfizer.

Biopharmas raising money in public or private financings, including: Appili.

New hires and promotions in the biopharma industry, including: Ascidian, Azafaros, Cambrian, Medigene, Nanoscope, Vectory.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Beigene, Biogen, Biontech, BMS, Cancervax, Celltrion, Charm, Coimmune, Coya, Dr. Reddy's, Genuv, Gilead, Janssen, Jatt, Leap Therapeutics, Nantpharma, Novartis, Nuriz, Oncoc4, Pear, RVAC Medicines, Sangamo, Sorrento, Spybiotech, Zura .

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Agendia, Enzo Biochem, Labcorp.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Aspivix.